Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aether Bio is a synthetic biology company that combines high-throughput robotic automation with machine learning to engineer novel enzymes. The company's platform is designed to map the relationship between protein sequences and functions, allowing for the rapid development of biocatalysts for industrial and pharmaceutical applications. Aether focuses on creating sustainable alternatives for chemical manufacturing, including lithium extraction and the production of high-value chemicals. By leveraging its proprietary AI models, the company aims to unlock new chemical reactions that were previously inaccessible through traditional methods. Their approach significantly reduces the time and cost associated with molecular discovery and process optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aether Bio.